Web Analytics

Investor Profile

DCVC Bio

DCVC Bio United States - Palo Alto, California
INVESTOR

1 Disclosed Funding Rounds $50,000,000
24 Participating Investments




DCVC Bio is a VC fund investing in early-stage computational biology startups. Advances in genetic sequencing, artificial intelligence and automation are converging to transform existing life

Invested In

Company Date Round Raised
  Solu Therapeutics August, 01 ,2023 Seed $31,000,000
  Elo Life Systems January, 25 ,2024 Series A $20,500,000
  Umoja Biopharma January, 21 ,2025 Series C $100,000,000
  Unlearn.AI April, 19 ,2022 Series B $50,000,000
  Ascend Gene & Cell Therapies May, 10 ,2023 Series A $132,500,000
  CH4Global August, 30 ,2023 Series B $29,000,000
  Latus Bio May, 03 ,2024 Series A $54,000,000
  Newleos Therapeutics February, 20 ,2025 Series A $93,500,000
  Solu Therapeutics August, 01 ,2023 Seed $31,000,000
  Radionetics Oncology January, 04 ,2024 Series A $52,500,000
  Umoja Biopharma January, 21 ,2025 Series C $100,000,000
  Elo Life Systems January, 25 ,2024 Series A $20,500,000
  CH4Global August, 30 ,2023 Series B $29,000,000
  Latus Bio May, 03 ,2024 Series A $54,000,000
  Newleos Therapeutics February, 20 ,2025 Series A $93,500,000
  Umoja Biopharma January, 21 ,2025 Series C $100,000,000
  Radionetics Oncology January, 04 ,2024 Series A $52,500,000
  Newleos Therapeutics February, 20 ,2025 Series A $93,500,000
  Elo Life Systems January, 25 ,2024 Series A $20,500,000
  Mainspring Energy April, 16 ,2025 Series F $258,000,000
  Latus Bio May, 03 ,2024 Series A $54,000,000
  Umoja Biopharma January, 21 ,2025 Series C $100,000,000
  Newleos Therapeutics February, 20 ,2025 Series A $93,500,000
  Mainspring Energy April, 16 ,2025 Series F $258,000,000